Eyedrops can be toxic to children
The FDA recently made a safety announcement to remind us to keep over the counter “red eye” medications like Visine and OptiClear out of the hands of our kids. Did … Continue reading
Bionic vision almost a reality
This week, a United States FDA panel recommended the Argus II retinal prosthesis chip for approval. Already in use in Europe, the Argus II chip has 60 electrodes that could … Continue reading
EYLEA approved to treat macular edema in central retinal vein occlusion
Yesterday, the drug EYLEA (aflibercept), an anti-vascular endothelial growth factor (VEGF) antibody, was approved by the FDA to treat macular edema associated with central retinal vein occlusion (CRVO). A central retinal … Continue reading
Are generic eye drops the same as brand name ones?
A recent editorial published in the medical journal, Ophthalmology, addressed a common concern: are generic eye drops the same as brand name eye drops when it comes to equal effect? … Continue reading
Lucentis approved for the treatment of diabetic macular edema
The FDA recently approved Lucentis (ranibizumab) for the treatment of diabetic macular edema (DME) (swelling in the retina due to diabetes). I am intimately familiar with Lucentis as I commonly use it … Continue reading
